Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 2 results out of 2
Data Insights
Adipose Tissue Derived Mesenchymal Stromal/Stem Cells by Cell2Cure for Diabetic Foot Ulcers: Likelihood of Approval
Adipose Tissue Derived Mesenchymal Stromal/Stem Cells is under clinical development by Cell2Cure and currently in Phase II for Diabetic Foot...
Data Insights
Adipose Tissue Derived Mesenchymal Stromal/Stem Cells by Cell2Cure for Diabetic Foot Ulcers: Likelihood of Approval
Adipose Tissue Derived Mesenchymal Stromal/Stem Cells is under clinical development by Cell2Cure and currently in Phase II for Diabetic Foot...